A detailed history of Means Investment Co., Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Means Investment Co., Inc. holds 32,546 shares of BMY stock, worth $1.39 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
32,546
Previous 33,877 3.93%
Holding current value
$1.39 Million
Previous $1.84 Million 26.46%
% of portfolio
0.16%
Previous 0.24%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$40.25 - $52.99 $53,572 - $70,529
-1,331 Reduced 3.93%
32,546 $1.35 Million
Q1 2024

Apr 17, 2024

SELL
$47.98 - $54.4 $336,675 - $381,724
-7,017 Reduced 17.16%
33,877 $1.84 Million
Q4 2023

Jan 25, 2024

SELL
$48.48 - $57.85 $481,842 - $574,971
-9,939 Reduced 19.55%
40,894 $2.1 Million
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $256,742 - $287,077
-4,435 Reduced 8.02%
50,833 $2.95 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $59,759 - $66,354
938 Added 1.73%
55,268 $3.53 Million
Q1 2023

May 08, 2023

SELL
$65.71 - $74.53 $1,182 - $1,341
-18 Reduced 0.03%
54,330 $3.77 Million
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $25,474 - $30,165
-372 Reduced 0.68%
54,348 $0
Q3 2022

Oct 17, 2022

BUY
$0.13 - $76.84 $33 - $19,747
257 Added 0.47%
54,720 $3.89 Million
Q2 2022

Jul 21, 2022

BUY
$72.62 - $79.98 $34,131 - $37,590
470 Added 0.87%
54,463 $4.19 Million
Q1 2022

Apr 26, 2022

SELL
$61.48 - $73.72 $1,905 - $2,285
-31 Reduced 0.06%
53,993 $3.94 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $16,249 - $18,943
303 Added 0.56%
54,024 $3.37 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $161,001 - $188,592
2,721 Added 5.34%
53,721 $3.18 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $18,263 - $19,888
-295 Reduced 0.58%
51,000 $3.41 Million
Q1 2021

Apr 05, 2021

SELL
$59.34 - $66.74 $192,024 - $215,970
-3,236 Reduced 5.93%
51,295 $3.24 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $4,388 - $4,972
76 Added 0.14%
54,531 $3.27 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $51,629 - $57,212
-899 Reduced 1.62%
54,455 $3.47 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $22,037 - $25,764
402 Added 0.73%
55,354 $3.49 Million
Q1 2020

Apr 23, 2020

SELL
$46.4 - $67.43 $92,846 - $134,927
-2,001 Reduced 3.51%
54,952 $3.35 Million
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $443,775 - $578,865
9,018 Added 18.81%
56,953 $3.8 Million
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $37,380 - $44,320
874 Added 1.86%
47,935 $2.72 Million
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $71,972 - $79,585
-1,613 Reduced 3.31%
47,061 $2.17 Million
Q1 2019

Apr 16, 2019

BUY
$45.12 - $53.8 $213,282 - $254,312
4,727 Added 10.76%
48,674 $2.32 Million
Q4 2018

Apr 16, 2019

BUY
$48.76 - $63.23 $2.14 Million - $2.78 Million
43,947 New
43,947 $2.28 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $90.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Means Investment Co., Inc. Portfolio

Follow Means Investment Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.